Safety and efficacy of a pneumococcal vaccine in young kids
Part of Ear, nose & throat clinical trials.
This study tests a new pneumococcal vaccine (wSp) in young children who have already had 3 doses of a standard pneumococcal shot. It aims to see if the new vaccine is safe and works well to protect against serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 6 months old (give or take about 2 months).
- Your child should be generally healthy with no known immune problems.
- Your child must have had 3 doses of a pneumococcal shot (PCV15 or PCV20).
- You must be willing to bring your child to every study visit and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
This study tests an experimental vaccine that protects against pneumococcal infections, which can cause pneumonia, meningitis, and ear infections. Your baby would get the vaccine as a series of three doses starting at about 2 months of age, followed by a booster around 12–15 months. The goal is to see how safe and how well-tolerated the vaccine is for infants.
This trial tests a new vaccine designed to protect against 24 types of pneumococcal bacteria (which cause pneumonia and other serious infections). Researchers are checking if it's safe and how well it works in infants, children, and adults.
This study tests a new pneumonia vaccine in healthy children to see if it is safe and works well. It may help protect your child from serious infections caused by the bacteria that lead to pneumonia.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
This trial tests a new 23-valent pneumococcal vaccine to see if it safely protects healthy people against pneumonia and other infections caused by pneumococcal bacteria.
Hear when a new Acute Otitis Media (AOM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.